Clinical Trials in Houston

Showing 3541-3560 of 15,366 trials

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

NCT05211284

Saroglitazar Magnesium 4 mg for NAFLD in People Living with HIV in the US

Zydus Therapeutics Inc.4 participantsStarted Dec 2022

Birmingham, Alabama, United States • La Jolla, California, United States • San Francisco, California, United States +5 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

NCT04437511

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab. Trial participants who were dosed with donanemab in the main study will be enrolled to a 3-year follow up addendum. No study drug will be administered during this follow up.

Alzheimer Disease

Eli Lilly and Company1,736 participantsStarted Jun 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +271 more locations

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Find Trials by Condition in Houston

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Examining the Feasibility and Acceptability of a Tailored Version of a Mindfulness-Based Intervention (MBI) Among Youth Experiencing Homelessness (YEH)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

A Study of LY3549492 in Healthy Weight Adult Participants

Mitral Valve Screening Survey

Long-Term Evaluation of BIIB067 (Tofersen)

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)